Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD: A Pilot Randomized Open-Label Trial | MicrobiomeTrials← Back to trialsNCT07654231
Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD: A Pilot Randomized Open-Label Trial
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-07-01Est. Completion: 2027-12-01
Enrollment target: 60 participants Locations- University of Texas Southwestern Medical Center, Dallas, Texas, United States
Other microbiome trials you might be interested in
Clonal Hematopoiesis of Indeterminate PotentialClonal Cytopenia of Undetermined Significance
Background:
Clonal Hematopoiesis of Indeterminate Potential (CHIP) is a change in a person s DNA that can increase a pe…
Bethesda, United StatesEst. completion Sep 15, 2033
Cachexia; Cancer
The goal of this clinical trial is to evaluate the efficacy and safety of ASCA101 for the treatment of Cachexia in solid…
Seoul, South KoreaEst. completion Apr 30, 2028